Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Konstantinos C. Spingos"'
Autor:
Emmanouil V. Dermitzakis, Aikaterini Kouroudi, Andreas A. Argyriou, Konstantinos C. Spingos, Konstantinos Bilias, Michail Vikelis
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract The Greek Society of Migraine and Headache Patients (GSMHP), maintaining a strong commitment to research and information, conducted its second web-based online survey named "Migraine in Greece—2020", following its first one conducted in 20
Externí odkaz:
https://doaj.org/article/acdac6bc40a14f63ab931e2854b42eef
Autor:
Michail Vikelis, Andreas A. Argyriou, Anastasia Antoniou, Konstantinos C. Spingos, Athanasios E. Skliros, Konstantinos Bilias, Aikaterini Kouroudi, Emmanouil V. Dermitzakis, Efstathios A. Skliros
Publikováno v:
Medicina, Vol 59, Iss 4, p 734 (2023)
Background and objectives: Migraine is considered the most clinically important primary headache due to its high prevalence and significant burden. Although globally categorized as one of the leading causes of disability, it is still largely underdia
Externí odkaz:
https://doaj.org/article/a36d14df24034cad935b0f37a4745300
Autor:
Emmanouil V. Dermitzakis, Aikaterini Kouroudi, Andreas A. Argyriou, Konstantinos C. Spingos, Konstantinos Bilias, Michail Vikelis
Publikováno v:
Medicina, Vol 59, Iss 1, p 31 (2022)
Background and Objectives: The Greek Society of Migraine and Headache Patients conducted, in 2020, its second online survey, titled “Migraine in Greece—2020”, after publication of the first similar online survey conducted in 2018. To compare th
Externí odkaz:
https://doaj.org/article/b96cea171394471db56896dce0e48765
Autor:
Michail Vikelis, Andreas A. Argyriou, Emmanouil V. Dermitzakis, Konstantinos C. Spingos, Nikolaos Makris, Evangelia Kararizou
Publikováno v:
The Journal of Headache and Pain, Vol 19, Iss 1, Pp 1-6 (2018)
Abstract Background Evidence on whether the therapeutic effect and good safety profile of onabotulinumtoxinA (Botox®) in chronic migraine (CM) patients is maintained over long term treatment is still limited. We herein aimed at assessing whether the
Externí odkaz:
https://doaj.org/article/173771faa18f49299caa929ff6629399
Autor:
Michail Vikelis, Emmanouil V. Dermitzakis, Konstantinos C. Spingos, Georgios G. Vasiliadis, George S. Vlachos, Evaggelia Kararizou
Publikováno v:
BMC Neurology, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background Migraine is included in the top-ten disabling diseases and conditions among the Western populations. Non-invasive neurostimulation, including the Cefaly® device, for the treatment of various types of pain is a relatively new fiel
Externí odkaz:
https://doaj.org/article/37978cc04dbc4d288ef2f5820ab931fc
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 8 (2015)
An iontophoretic transdermal system (ITS) (skin patch) formulation of sumatriptan for the acute treatment of migraine attacks was approved by the US Food and Drug Administration in January 2013. This transdermal system bypasses the gastrointestinal t
Externí odkaz:
https://doaj.org/article/b0053444496d43b4a3c9e49570e44d41
Autor:
Konstantinos C. Spingos, Georgios S. Vlachos, Emmanouil V. Dermitzakis, Andreas A. Argyriou, Pantelis Litsardopoulos, Panagiotis Soldatos, Michail Vikelis, Evangelia Kararizou
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 1
Journal of Clinical Medicine, Vol 10, Iss 67, p 67 (2021)
Volume 10
Issue 1
Journal of Clinical Medicine, Vol 10, Iss 67, p 67 (2021)
Background: To investigate the efficacy and safety of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 in episodic migraine (EM) prevention. Methods: A pilot, single-arm, open-label
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ef41a7565f3941a0172be27ea489b38
Autor:
Michail Vikelis, Emmanouil V. Dermitzakis, Georgios S. Vlachos, Panagiotis Soldatos, Konstantinos C. Spingos, Pantelis Litsardopoulos, Evangelia Kararizou, Andreas A. Argyriou
BackgroundTo investigate efficacy and safety of a supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 (Vivinor®) in episodic migraine prevention.MethodsAn observational, prospective,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56ce623906a9b14ac53363ad9ca06301
https://doi.org/10.21203/rs.3.rs-50685/v1
https://doi.org/10.21203/rs.3.rs-50685/v1
Autor:
Evaggelia Kararizou, Konstantinos C. Spingos, Emmanouil V. Dermitzakis, Michail Vikelis, George S. Vlachos, Georgios G. Vasiliadis
Publikováno v:
BMC Neurology, Vol 17, Iss 1, Pp 1-7 (2017)
BMC Neurology
BMC Neurology
Background Migraine is included in the top-ten disabling diseases and conditions among the Western populations. Non-invasive neurostimulation, including the Cefaly® device, for the treatment of various types of pain is a relatively new field of inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8dd7d6b2cda6d8ebf3f78be6204b205
http://link.springer.com/article/10.1186/s12883-017-0869-3
http://link.springer.com/article/10.1186/s12883-017-0869-3
Autor:
Andreas A. Argyriou, Nikolaos Makris, Michail Vikelis, Evangelia Kararizou, Konstantinos C. Spingos, Emmanouil V. Dermitzakis
Publikováno v:
The Journal of Headache and Pain
The Journal of Headache and Pain, Vol 19, Iss 1, Pp 1-6 (2018)
The Journal of Headache and Pain, Vol 19, Iss 1, Pp 1-6 (2018)
Background Evidence on whether the therapeutic effect and good safety profile of onabotulinumtoxinA (Botox®) in chronic migraine (CM) patients is maintained over long term treatment is still limited. We herein aimed at assessing whether there is a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2cb8d999566cf67146d37f9da223e7a
https://pubmed.ncbi.nlm.nih.gov/30225735
https://pubmed.ncbi.nlm.nih.gov/30225735